Queensland has long been an ideal destination for early-phase clinical trials.
On May 20, the Shanghai–Queensland Biopharmaceutical Industry Development Seminar was successfully held at the Medical Device Innovation Center in the Lin-gang Special Area of Shanghai.
The event brought together dozens of professionals from the biomedicine sector. Discussions focused on key topics such as Queensland’s advantages in clinical trials, the role of clinical research in driving internationalization of the biopharmaceutical industry, and the transformation and global expansion of clinical drug development in China.
Read More：
